Canadian Leadership Council on Drug Plan Partnerships

 

On Wednesday May 7, Human Capital Benefits was invited to participate in the 2025 Canadian Leadership Council on Drug Plan Partnerships in downtown Toronto. This meeting was designed to foster dynamic group discussion, examine the challenges of Canadian private drug plans and explore ideas and solutions for plan sponsors.

The session was facilitated through Benefits Canada .   Special thanks to sponsors of the session;  Abbvie, Amgen, AstraZeneca, Innovative Medicines Canada, GSK Canada, Novo Nordisk, Pfizer and Health Solutions by Shoppers.

Insights

More Related Articles

Human Capital Benefits Benchmarking Tool – Coming Soon

Canadian Insurer details on coverage for Wegovy for cardiovascular treatment

Verbal Offer, Offer Letters and Employment Agreements